PDS Biotechnology Stock (NASDAQ: PDSB) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 409.83K |
Day Range | - - - |
52 Wk Range | 2.53 - 6.85 |
Market Cap | $119.02M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 54 |
Short Interest | 13.38% |
Days to Cover | 25.08 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of PDS Biotechnology (NASDAQ:PDSB) through any online brokerage.
Other companies in PDS Biotechnology’s space includes: Skye Bioscience (NASDAQ:SKYE), Anixa Biosciences (NASDAQ:ANIX), Citius Oncology (NASDAQ:CTOR), Adicet Bio (NASDAQ:ACET) and Agenus (NASDAQ:AGEN).
PDS Biotechnology has a consensus price target of $14.60.
The stock price for PDS Biotechnology (NASDAQ: PDSB) is $3.2325 last updated September 23, 2024 at 9:15 AM EDT.
There are no upcoming dividends for PDS Biotechnology.
PDS Biotechnology’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for PDS Biotechnology.
PDS Biotechnology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.